Results 21 to 30 of about 51,551 (285)

Adeno‐associated virus serotype 2 capsid variants for improved liver‐directed gene therapy

open access: yesHepatology, EarlyView., 2022
Abstract Background and Aims Current liver‐directed gene therapies look for adeno‐associated virus (AAV) vectors with improved efficacy. With this background, capsid engineering is explored. Whereas shuffled capsid library screenings have resulted in potent liver targeting variants with one first vector in human clinical trials, modifying natural ...
Nadja Meumann   +25 more
wiley   +1 more source

Effects of Immunization with Recombinant Schistosoma mansoni Enzymes AK and HGPRT: Murine Infection Control

open access: yesPathogens, 2023
Schistosomiasis is one of the most important human helminthiases worldwide. Praziquantel is the current treatment, and no vaccine is available until the present.
Ana Carolina Maragno Fattori   +10 more
doaj   +1 more source

Structure, expression, and mutation of the hypoxanthine phosphoribosyltransferase gene.

open access: greenProceedings of the National Academy of Sciences of the United States of America, 1984
D. Melton   +3 more
semanticscholar   +3 more sources

Research Advances in Purine Phosphoribosyltransferases of Protozoan Parasites

open access: yesGuangdong nongye kexue, 2023
Parasitic protozoa are single-celled organisms that have adapted to live in cells of humans and animals. The protozoan parasites include Leishmania spp., Trypanosoma spp., Plasmodium spp., Toxoplasma gondii, Cryptosporidium spp., and Eimeria spp., which ...
Zhihui YU   +7 more
doaj   +1 more source

Analysis of parameters of purine metabolism in patients with diabetes mellitus type 2

open access: yesMedičnì Perspektivi, 2023
The aim of this research is to comprehensively analyze the current state of purine metabolism as well as assess its features in patients with diabetes mellitus type 2, taking into account the clinical and metabolic polymorphism of the disease.
A.O. Chernyaeva   +2 more
doaj   +1 more source

Targeted Knock-in of Transgenes into the CHO Cell Genome Using CRISPR-mediated Integration Systems [PDF]

open access: yesMATEC Web of Conferences, 2021
Biopharmaceutical proteins are usually produced by culturing recombinant Chinese hamster ovary (CHO) cells. High producer cell lines are screened from transfected cells with random integration of target genes. Since transgene expression is susceptible to
Iwao Ryusei   +4 more
doaj   +1 more source

PRTFDC1 is a genetic modifier of HPRT-deficiency in the mouse. [PDF]

open access: yesPLoS ONE, 2011
Lesch-Nyhan disease (LND) is a severe X-linked neurological disorder caused by a deficiency of hypoxanthine phosphoribosyltransferase (HPRT). In contrast, HPRT-deficiency in the mouse does not result in the profound phenotypes such as self-injurious ...
Alaine C Keebaugh   +6 more
doaj   +1 more source

Normal Uricemia in Lesch–Nyhan Syndrome and the Association with Pulmonary Embolism in a Young Child—A Case Report and Literature Review

open access: yesPediatrics and Neonatology, 2014
Deficiency of hypoxanthine phosphoribosyltransferase activity is a rare inborn error of purine metabolism with subsequent uric acid overproduction and neurologic presentations.
Jeng-Dau Tsai   +5 more
doaj   +1 more source

Chinese Hamster Hypoxanthine-Guanine Phosphoribosyltransferase

open access: hybridJournal of Biological Chemistry, 1974
Anne S. Olsen, Gregory Milman
openalex   +2 more sources

Reduced levels of dopamine and altered metabolism in brains of HPRT knock-out rats: a new rodent model of Lesch-Nyhan Disease [PDF]

open access: yes, 2016
Lesch-Nyhan disease (LND) is a severe neurological disorder caused by loss-of-function mutations in the gene encoding hypoxanthine phosphoribosyltransferase (HPRT), an enzyme required for efficient recycling of purine nucleotides.
AM Geurts   +45 more
core   +4 more sources

Home - About - Disclaimer - Privacy